CLEAR OUTCOMES showed bempedoic acid: - 🔽 prim endpoint vs placebo in statin intolerant pts - Driven by 🔽 MI and Cor Revasc - ↔️ CVD or Mortality Any serial CCTA to assess plaque stability? #ACC23 #ACCinTouch #ACCImaging Marcelo Di Carli Ron Blankstein Emilio Fentanes A. Michael Lincoff, MD

TRILUMINATE - edge/edge TV repair: - Met prim endpt driven by ⏫ QoL - 125/175 >2 TR sev; ↔️ Mort, Hosp - Too dilated/sick/old for outcome benefit? Would ❤️ to see cMRI RV size/fnx based enrollment & outcome strat #WhyCMR #ACC23 #WCCardio #ACCImaging Dr. Purvi Parwani Nadira Hamid

STOP-CA: Atorvastatin on LVEF for Anthracycline Cardiotoxicity - 9% ⏬ EF >10% to <55% vs 22% Plcb - EF 63% ➡️ 59% vs 63% ➡️ 57% Plcb - Mean atorva ⏬ 1.3% P=0.029 **Intraobs variab cMRI LVEF ~3-7% Clinically meaningful? Victor Farah, MD Joshua Mitchell Joshua Levenson, MD #ACCImaging

TARGET: CCTA + On-site CT-FFR - ⏬ in Cath with No CAD or CAD w/o PCI vs SOC (Predom stress ECG); ↔️ MACE/Cost - Would love to know: 1) Turn around time? 2) Rejection rate? 3) Vendor compatibility? #ACC23 #ACCImaging #WCC2023 Brian with the Good Dictations Ron Blankstein Matthew Budoff MD Quynh Truong

Improving access, decreasing scan times, refining protocols, resonating with your C-suite were all brilliantly discussed by Lauren A. Baldassarre, MD, FACC, FSCCT, FSCMR @HeartDocSubha 👏 IHS is committed to meet the growing demand and need for cMRI #ACCImaging #whyCMR Emilio Fentanes Dr. Purvi Parwani

Congrats Kaitlin Marquis !!

Excited for tonight's online conference on multimodality imaging in cardio-oncology patients! Join us for the latest advancements with top experts in the field. Don't miss out on this unique opportunity to expand your knowledge! #ACCimaging #CardioOncology

1/6 A career in cardiovascular imaging can take many shapes, and affords a wide variety of potential opportunities and areas of focus. Take a look at how five #ACCimaging early career faculty members spend their time. American College of Cardiology #ACCFIT

The role of perivascular adipose tissue as a clinically relevant source of diagnostic and prognostic biomarkers of vascular function. Read the clinical consensus statement in #EHJ. doi.org/10.1093/eurhea… #atherosclerosis #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

Vegetarian and vegan diets: benefits and drawbacks. Read the latest State of the Art Review in #EHJ: academic.oup.com/eurheartj/arti… #nutrition #diet #vegetarian #vegan #CVD #cardiotwitter European Society of Cardiology European Society of Cardiology Journals

‼️ Excited to release my first CardioNerds infographic on inotropes. 🥳I learned so much while putting this together and I hope you can use this information to help others! 🫀 Shout out to Eunice Dugan, MD for guiding me! 🙏 (click on the image to get all the info!🤓)

JACC Journals Answer: Single coronary with anomalous LM arising from the RCA with a transseptal/subpulmonic course and a long intramyocardial segment. Given recurrent CP, pt underwent external unroofing. Avoid CABG alone in pts w/ good forward flow due to high likelihood of graft failure.

Join us Thursday, December 14th for Medicine Grand Rounds. Farhan M. Katchi, MD, FCC Farhan Katchi, MD WashU Medicine Cardiovascular Division Test Account presents: "Evolving Role of Coronary CT Imaging to Predict Cardiovascular Risk" We hope you'll join us to support the speaker. Link> l8r.it/E4rt

Last week's Medicine Grand Rounds video presentation is now available for viewing on our #WUDeptMedicine YouTube Channel.⁠ ⁠ Farhan M. Katchi, MD, FACC Farhan Katchi, MD WashU Medicine Cardiovascular Division @MIRImaging Test Account presented. ⁠⁠ Click the link for the presentation> l8r.it/r1zt

Loved working with 🌟 American College of Cardiology FIT Aakash Bavishi on this sports cardiology piece 👇on advising symptomatic athletes on their training regimen during their diagnostic evaluation. #SportsCardio acc.org/education-and-…

i mean it when i say that the Apple Vision Pro will be a game changer for education here’s how I studied the heart 5 years ago vs how I can study it today, credit to the visionOS app Insight Heart the contrast in experience and comprehension can’t be denied

Unlocking colchicine's potential in cardiovascular care: a must-read review article Leo Buckley ahajrnls.org/3TAYaX6

Very nice discussion on relapsed #SCLC by Dr. Anjali Rohatgi at #WCLC24. ADCs showing promise and easier to deliver than a BiTE like tarlatamab. No clear biomarker but encouraging efficacy. But we need randomized data to provide clear perspective.

👏👏👏

These sorts of billing games should be in everyone’s radar.